Earliest predictors of language outcomes in high-risk infants
Earliest predictors of language outcomes in high-risk infants
批准号:
10841986
负责人:
Lisa Leigh Hunter
金额:
$45.31万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-01 至 2025-02-28
关键词:
3 year oldAgeAuditoryAuditory Brainstem ResponsesAuditory ThresholdBehaviorBehavioralBiological MarkersBirthBrainChildCochlear implant procedureCommunicationControl GroupsDataEarly DiagnosisEarly InterventionEarly identificationElectroencephalographyEnrollmentFrequenciesFundingGestational AgeGesturesGoalsHearingHearing TestsHearing problemInfantInterventionLanguageLanguage DelaysLanguage DevelopmentLanguage DisordersLanguage TherapyLifeLongitudinal cohortMagnetic Resonance ImagingMeasuresNeonatalNeurodevelopmental DisorderNeuronal PlasticityNonverbal CommunicationNursery SchoolsParentsPhysiologicalPopulationPredictive FactorPremature BirthPremature InfantProtocols documentationPublishingRaceReportingRiskRisk FactorsSamplingSchool-Age PopulationSocioeconomic StatusSpeechSpeech DisordersStandardizationSurvivorsTherapeutic StudiesToddlerValidationVideo Recordingagedcohortextreme prematurityhearing impairmenthearing screeninghigh risk infantinnovationlanguage disorder diagnosislanguage outcomeneurophysiologynovelotoacoustic emissionoutcome predictionparent grantpermanent hearing losspredictive modelingresponsescreeningsexskillssocial communicationspeech processingsupport networkverbal
中文摘要
在美国,每九个婴儿中就有一个早产。言语、语言和听力障碍
(SLD)是儿童中最常见的神经发育障碍之一,特别是
早产儿幸存者中。约40%的极早产儿(胎龄≤32周)
10%的人患有语言障碍,而10%的人患有永久性听力损失,
影响沟通困难。目前,还无法准确预测第一次
几年的生活,儿童将发展语言障碍,和语言-
语言治疗是对早产儿提供的所有干预措施中最延迟的。这样的
这一进展将有助于在关键窗口期进行早期干预和研究治疗,
最佳神经可塑性我们的中心假设是,言语语言障碍的预测是
可能通过3 m校正年龄(CA)结合结构和
功能性脑连接与磁共振成像,诱发反应的措施,
语音处理,以及新的,敏感的听力措施。本补充的主要目的
目标:1。比较足月和早产儿的语言、非语言和社会交流
幼儿目标2.比较足月和早产儿的听力灵敏度(cABR和DPOAE)
以及足月和早产幼儿的行为测听。比较rsfEEG和MMR
本研究将招募健康的足月儿,
在3个月时进行全面的听力和神经生理学测量,
在2年CA时进行评估,以与匹配的早产儿进行比较。
英文摘要
One in every nine babies in the US is born preterm. Speech, language and hearing disorders
(SLD) are among the most prevalent neurodevelopmental disorders in children, especially
among very preterm survivors. About 40% of very preterm infants (≤32 weeks gestational age)
develop speech-language disorders while 10% have permanent hearing loss, increasing the
impact on communication difficulties. Currently, it is not possible to accurately predict in the first
several years of life which children will develop speech-language disorders, and speech-
language therapy is the most delayed of any intervention provided to preterm infants. Such an
advance would facilitate early intervention and research therapies during critical windows of
optimal neuroplasticity. Our central hypothesis is that prediction of speech-language disorders is
possible by 3 m corrected age (CA) with combined innovative measures of structural and
functional brain connectivity with magnetic resonance imaging, evoked response measures of
speech processing, and novel, sensitized hearing measures. Primary aims of this supplement
are: Aim 1. Compare verbal, nonverbal, and social communication in full-term and preterm
toddlers. Aim 2. Compare hearing sensitivity (cABR and DPOAE) in full-term and preterm
infants, and behavioral audiometry in full-term and preterm toddlers. Compare rsfEEG and MMR
in full-term and preterm infants.This study will enroll healthy, fullterm children to collect
comprehensive hearing and neurophysiologic measures at 3 months, and language and hearing
assessment at 2 years CA for comparison to matched preterm children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Earliest predictors of language outcomes in high-risk infants
-
批准号:10579249
-
项目类别:
-
资助金额:$63.82万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
Earliest predictors of language outcomes in high-risk infants
-
批准号:10116363
-
项目类别:
-
资助金额:$66.7万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
Earliest predictors of language outcomes in high-risk infants
-
批准号:10357782
-
项目类别:
-
资助金额:$65.67万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
Supplement - Earliest Predictors of Language Outcomes in High-risk Infants
-
批准号:10513836
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2020
-
负责人:Lisa Leigh Hunter
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: